Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sanjeeva Reddy Onteddu

Concepts (124)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
10
2022
492
3.590
Why?
Thrombolytic Therapy
4
2022
110
1.430
Why?
Fibrinolytic Agents
4
2022
124
1.420
Why?
Tissue Plasminogen Activator
3
2020
109
1.380
Why?
Brain Ischemia
5
2022
161
1.260
Why?
Nervous System Diseases
2
2020
88
1.140
Why?
Thrombectomy
2
2020
67
0.880
Why?
Pneumonia, Viral
3
2020
168
0.870
Why?
Coronavirus Infections
3
2020
177
0.850
Why?
Pandemics
5
2020
559
0.840
Why?
Intracranial Thrombosis
1
2020
16
0.750
Why?
Health Services Misuse
1
2020
13
0.720
Why?
Time-to-Treatment
1
2020
61
0.710
Why?
Conflict of Interest
1
2020
25
0.700
Why?
Patient Transfer
1
2020
94
0.690
Why?
Venous Thrombosis
1
2020
90
0.690
Why?
Fabry Disease
1
2019
9
0.670
Why?
Enzyme Replacement Therapy
1
2019
17
0.670
Why?
Emergency Service, Hospital
2
2020
486
0.660
Why?
Ischemic Attack, Transient
1
2019
56
0.650
Why?
Cardiology
1
2020
89
0.640
Why?
Leukoaraiosis
1
2015
1
0.530
Why?
Recovery of Function
2
2019
188
0.520
Why?
Hypoxia-Ischemia, Brain
1
2014
54
0.440
Why?
Hospitalization
4
2021
652
0.430
Why?
Telemedicine
1
2019
448
0.420
Why?
Heart Arrest
1
2014
149
0.410
Why?
Humans
23
2022
49974
0.400
Why?
Aged
10
2021
9310
0.380
Why?
Triage
2
2021
62
0.360
Why?
Retrospective Studies
6
2020
6108
0.350
Why?
Middle Aged
10
2021
12069
0.340
Why?
Autoimmune Diseases
2
2020
101
0.340
Why?
Endovascular Procedures
2
2022
173
0.340
Why?
Immunosuppressive Agents
2
2020
221
0.330
Why?
Male
13
2021
25241
0.300
Why?
Female
13
2021
26472
0.300
Why?
United States
5
2020
4860
0.290
Why?
Arkansas
4
2019
1977
0.270
Why?
Time Factors
4
2020
2903
0.270
Why?
Tomography, X-Ray Computed
3
2020
1159
0.230
Why?
Treatment Outcome
5
2022
5141
0.230
Why?
Follow-Up Studies
2
2020
2182
0.220
Why?
Cavernous Sinus
1
2022
15
0.200
Why?
Carotid-Cavernous Sinus Fistula
1
2022
11
0.200
Why?
Critical Care
2
2021
213
0.200
Why?
Sinus Thrombosis, Intracranial
1
2021
17
0.190
Why?
Myasthenia Gravis
1
2021
17
0.190
Why?
Embolization, Therapeutic
1
2022
88
0.180
Why?
Neuromuscular Diseases
1
2020
30
0.180
Why?
Iodine Compounds
1
2020
7
0.180
Why?
Multiple Sclerosis
1
2020
66
0.180
Why?
Health Care Sector
1
2020
15
0.180
Why?
Databases, Factual
2
2020
658
0.180
Why?
Cohort Studies
2
2022
1422
0.180
Why?
Drug Industry
1
2020
38
0.170
Why?
Brain Edema
1
2020
41
0.170
Why?
Administration, Oral
1
2020
426
0.170
Why?
alpha-Galactosidase
1
2019
9
0.170
Why?
Disease Outbreaks
1
2020
125
0.170
Why?
Fluorocarbons
1
2019
45
0.170
Why?
Hospitals
1
2020
175
0.170
Why?
Hemorrhage
1
2020
197
0.160
Why?
Prevalence
3
2020
944
0.160
Why?
Contrast Media
1
2020
184
0.160
Why?
Medicare
1
2020
246
0.160
Why?
Neuroprotective Agents
1
2019
105
0.160
Why?
Coronary Angiography
1
2020
334
0.160
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
130
0.150
Why?
Physicians
1
2020
233
0.140
Why?
Referral and Consultation
1
2019
285
0.140
Why?
Adult
5
2020
13236
0.140
Why?
Plasminogen Activators
1
2015
3
0.130
Why?
Statistics, Nonparametric
1
2015
194
0.130
Why?
Prospective Studies
1
2020
2364
0.120
Why?
Forensic Pathology
1
2014
7
0.120
Why?
Analysis of Variance
1
2015
562
0.120
Why?
Autopsy
1
2014
46
0.120
Why?
Optic Neuritis
1
2013
21
0.110
Why?
Malaria, Falciparum
1
2013
13
0.110
Why?
Severity of Illness Index
1
2015
945
0.100
Why?
Aged, 80 and over
2
2019
3129
0.100
Why?
Health Behavior
1
2014
254
0.100
Why?
Socioeconomic Factors
1
2014
581
0.100
Why?
Risk Factors
2
2019
3613
0.090
Why?
Intubation, Intratracheal
2
2021
118
0.080
Why?
Magnetic Resonance Imaging
1
2015
1537
0.080
Why?
Intracranial Hemorrhages
1
2022
38
0.050
Why?
Cerebral Hemorrhage
1
2022
104
0.050
Why?
Headache
1
2022
76
0.050
Why?
Cranial Sinuses
1
2021
10
0.050
Why?
Arthritis, Psoriatic
1
2020
9
0.050
Why?
Spondylitis, Ankylosing
1
2020
9
0.050
Why?
Disease Susceptibility
1
2021
89
0.050
Why?
Osmolar Concentration
1
2020
62
0.050
Why?
Colitis, Ulcerative
1
2020
50
0.040
Why?
Mortality
1
2020
99
0.040
Why?
Neurologic Examination
1
2020
77
0.040
Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.040
Why?
Arthritis, Rheumatoid
1
2020
105
0.040
Why?
Registries
1
2022
522
0.040
Why?
Maximum Tolerated Dose
1
2019
37
0.040
Why?
Crohn Disease
1
2020
90
0.040
Why?
Neuroimaging
1
2020
84
0.040
Why?
Tertiary Care Centers
1
2019
77
0.040
Why?
Subarachnoid Hemorrhage
1
2020
65
0.040
Why?
Drug-Eluting Stents
1
2020
93
0.040
Why?
Administration, Intravenous
1
2019
69
0.040
Why?
Disability Evaluation
1
2019
87
0.040
Why?
Electronic Health Records
1
2021
209
0.040
Why?
Drug Administration Schedule
1
2019
376
0.040
Why?
Comorbidity
1
2019
615
0.040
Why?
Patient Readmission
1
2019
219
0.040
Why?
Double-Blind Method
1
2019
681
0.040
Why?
Diagnosis, Differential
1
2020
1037
0.030
Why?
Myocardial Infarction
1
2020
389
0.030
Why?
Percutaneous Coronary Intervention
1
2020
297
0.030
Why?
Risk Assessment
1
2019
1259
0.030
Why?
Cross-Sectional Studies
1
2019
1557
0.030
Why?
Antimalarials
1
2013
23
0.030
Why?
Infant
1
2020
3567
0.030
Why?
Child, Preschool
1
2020
3871
0.020
Why?
Adolescent
1
2020
6356
0.020
Why?
Child
1
2020
6847
0.020
Why?
Onteddu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description